Gonadorelin Acetate

Extensively Studied

Decapeptide

Gonadorelin is a synthetic decapeptide identical to gonadotropin-releasing hormone (GnRH). It has been extensively studied in reproductive endocrinology research for its role in stimulating gonadotropin release from the anterior pituitary. Published research has investigated its effects on the hypothalamic-pituitary-gonadal axis in various laboratory models. RaysunPeptide supplies Gonadorelin Acetate for qualified research and laboratory applications.

Mechanism of Action

Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.

Key Benefits

01Stimulates natural testosterone production
02Maintains testicular function during hormone therapy
03Supports fertility in hypogonadal conditions
04FDA-approved for diagnostic and therapeutic use
05Can restore LH and FSH pulsatility
06Alternative to hCG for testicular stimulation
07Preserves endogenous hormone production

Molecular Data

Molecular Weight
1,182.3 Da
Half-Life
2-4 minutes
Chain Length
10 amino acids
Amino Acid Sequence
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2

Dosing Protocols

GoalDoseFrequencyRoute
Diagnostic testing100 mcgSingle injectionSubQ or IV
Fertility support50-100 mcg2-3x weeklySubQ
Pulsatile therapy5-20 mcg per pulseEvery 90-120 minSubQ pump
TRT adjunct100-200 mcg2-3x weeklySubQ

Research Indications

Fertility & Reproductive

Hypogonadotropic Hypogonadismmost effective

Treatment of conditions like Kallmann syndrome where GnRH deficiency causes low testosterone and infertility.

Ovulation Inductionmost effective

Induces ovulation in women with hypothalamic amenorrhea who don't ovulate regularly.

Male Fertilityeffective

Stimulates testosterone and sperm production by restoring LH/FSH pulsatility.

Delayed Pubertyeffective

Treatment of delayed puberty due to hypothalamic-pituitary dysfunction.

Diagnostic

Pituitary Function Testingmost effective

Used to assess hypothalamic-pituitary function and diagnose GnRH deficiency.

LH/FSH Response Assessmentmost effective

Evaluates pituitary reserve and responsiveness to GnRH stimulation.

Hormone Optimization

TRT Supporteffective

Maintains testicular function and fertility during testosterone replacement therapy.

Post-Cycle Therapymoderate

Helps restore natural testosterone production after anabolic steroid use.

Cryptorchidismmoderate

Treatment of undescended testes in pediatric patients.

Peptide Interactions

hCG+ compatible

Often used as alternative to hCG for testicular stimulation during TRT.

Testosterone++ synergistic

Used alongside TRT to maintain testicular function and fertility.

Clomiphene+ compatible

Can be combined in fertility and PCT protocols.

Kisspeptin++ synergistic

Kisspeptin stimulates GnRH release; can work together for hormone optimization.

What to Expect

1
Within minutes
LH and FSH release begins
2
Hours
Testosterone increase in response to LH
3
Week 1-2
Improved hormonal markers on blood tests
4
Week 2-4
Restoration of natural hormone pulsatility
5
Ongoing
Maintained testicular function and fertility

Side Effects & Safety

Common (Generally Mild)

  • •Injection site reactions
  • •Headache
  • •Flushing
  • •Nausea
  • •Abdominal discomfort

Stop Signs (Seek Medical Attention)

  • ⚠Signs of allergic reaction (rash, difficulty breathing)
  • ⚠Severe headaches
  • ⚠Unusual abdominal pain

Contraindications

  • ✕Hormone-sensitive tumors
  • ✕Pregnancy
  • ✕Hypersensitivity to GnRH or analogs
  • ✕Conditions worsened by sex hormone release

Quality Checklist

Good Signs ✓

  • White lyophilized powder
  • Clear solution after reconstitution
  • Intact vacuum seal

Warning Signs !

  • Slight clumping that dissolves easily

Bad Signs ✕

  • Discolored powder
  • Cloudy or particulate solution
  • Broken seal

References

Gonadorelin in Hypogonadotropic Hypogonadism
• Journal of Clinical Endocrinology & Metabolism • 2018

Pulsatile GnRH administration effectively restores fertility in patients with hypothalamic hypogonadism.

GnRH Pulsatility and Reproductive Function
• Frontiers in Endocrinology • 2020

Pulsatile GnRH secretion (every 60-120 min) is essential for proper FSH/LH release and reproductive function.

Gonadorelin for Ovulation Induction
• Fertility and Sterility • 2015

Effective treatment for ovulation induction in women with hypothalamic amenorrhea.

FAQs

Why is pulsatile Gonadorelin dosing critical, and what happens with continuous dosing?

Gonadorelin must be dosed in pulses (every 90-120 minutes) to mimic natural GnRH secretion patterns. Continuous exposure paradoxically causes GnRH receptor desensitization and downregulation, suppressing LH and FSH release—the opposite of desired effects. Proper pulsatile timing is essential for therapeutic success.

Is Gonadorelin better than hCG for maintaining testicular function during TRT?

Both Gonadorelin and hCG maintain testicular function and fertility during TRT, but they work differently. hCG directly mimics LH with a 24-36 hour half-life, while Gonadorelin stimulates natural LH/FSH release but requires pulsatile dosing. hCG is simpler to administer; Gonadorelin offers more physiological restoration of the HPG axis.

How quickly does Gonadorelin raise testosterone after injection?

Gonadorelin has an extremely short 2-4 minute half-life, triggering LH release within minutes. Testosterone elevation from LH stimulation begins within hours, with peak levels at 6-12 hours post-injection. This rapid response makes it suitable for diagnostic testing and pulsatile protocols.

Can Gonadorelin be used long-term for post-cycle therapy, or just short-term?

Gonadorelin is effective for both acute (diagnostic) use and extended post-cycle protocols lasting 2-3 weeks. However, its extreme sensitivity to dosing frequency makes it less practical long-term than hCG or clomiphene. Most PCT protocols use Gonadorelin initially then transition to other agents for maintenance.

Gonadorelin Acetate

Dosing Summary

Dose
100-200 mcg for single injections; 5-20 mcg per pulse for pulsatile therapy
Frequency
2-3 times weekly for fertility/TRT support; every 90-120 minutes for pulsatile therapy; single dose for diagnostic
Cycle
Varies - diagnostic single use, fertility therapy ongoing, TRT support continuous
Storage
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 14 days due to short stability

Specifications

Purity≥98% (HPLC verified)
FormLyophilized powder
Packaging2mg
StorageStore at -20°C, protect from light
Catalog No.GND2

Research Data

3
Studies
2020
Latest
0
Recent

Available Sizes

2mg$22